EP0448656A1 - Elongate container having two compartments, one being an extension of the other. - Google Patents
Elongate container having two compartments, one being an extension of the other.Info
- Publication number
- EP0448656A1 EP0448656A1 EP90912873A EP90912873A EP0448656A1 EP 0448656 A1 EP0448656 A1 EP 0448656A1 EP 90912873 A EP90912873 A EP 90912873A EP 90912873 A EP90912873 A EP 90912873A EP 0448656 A1 EP0448656 A1 EP 0448656A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- zone
- neck
- compartment
- container according
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims description 28
- 239000011324 bead Substances 0.000 claims description 11
- 239000007789 gas Substances 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 210000000056 organ Anatomy 0.000 claims 1
- 238000007789 sealing Methods 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 description 9
- 238000006073 displacement reaction Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 5
- 230000004913 activation Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000009434 installation Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229940041010 fourth-generation cephalosporins Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2041—Separating means having removable plugs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S215/00—Bottles and jars
- Y10S215/08—Mixing
Definitions
- the present invention relates to an elongated container having two separate compartments arranged in the extension of one another, the first of which contains a liquid and the second either a liquid, a powder or a lyophilisate, these substances being intended to be mixed in the second compartment, this container comprising a central cylindrical throttle in which is disposed an intermediate closure plug arranged to separate the two compartments during storage of the container, as well as an open cylindrical neck of section narrowed with respect to those of said compartments, in which is engaged a movable closure member comprising at least one active part, arranged to be moved between a first so-called storage position, in which it constitutes a sealed shutter, and a second so-called use position.
- Containers are already known, in particular for medical use, with two compartments intended to contain respectively a liquid, a powdery substance or a lyophilisate and a liquid solvent, and which are separated during storage by a removable intermediate plug.
- a container is for example described in French patent No. 1.0 -686 which has a tubular bottle which has, in its middle, a throttle in the form of a “V” bead in which is tightened an intermediate closure plug which separates the two compartments.
- the bottle is open at its two ends which are closed, after filling the compartments, by means of closure plugs and, in other versions, the bottle is only open at one of its ends.
- the bottle has a substantially cylindrical shape over its entire length, apart from the central annular bead which retains the intermediate closure cap.
- This type of bottle has many drawbacks due to its construction.
- the annular bead has an internal diameter which is slightly different from that of the two cylindrical chambers arranged on either side of this bead, this in order to allow guiding and positioning of the intermediate closure plug. But this construction generates a defect.
- the cap When the cap is pushed back to allow the components to be mixed, if it goes wrong, it can become blocked between the walls of the lower chamber, preventing the flow of the liquid and finally the mixing of the components. This can happen because the diameter of the vial is less than the measurement of the diagonal of the intermediate stopper.
- the intermediate closure plug is only weakly retained by the bead.
- the seal between the two compartments is questionable.
- a pressure inadvertently exerted on the end plug generates a displacement of the intermediate plug and a risk of accidental transfer of the liquid from one to the other compartment.
- the obturator of the neck of the vial must be put in place by means of special packaging machines, to allow the evacuation of a volume of air substantially equivalent to the volume of the part of the obturator entering the neck, in order to avoid an overpressure liable to move the intermediate closure plug axially.
- These machines are expensive, cannot reach high speeds and require pressure control means.
- the present invention proposes to overcome all of these drawbacks and to provide a sum of interesting solutions both in terms of filling and in use.
- the content of the invention fully meets the current requirements of the pharmaceutical industry and the medical community which are:
- the container according to the invention is characterized in that the neck comprises a first zone close to the open end and a second zone formed between said first zone and the interior of the container, in that said second zone has a cross section less than that of the first zone, in that the first zone has a cross section greater than that of said active part of the movable closure member and in that the second zone has a section at most equal to that of this active part.
- said active part of the movable closure member has a section greater than that of said second zone so that this part is compressed when it is engaged in said zone.
- the movable closure member comprises at least one bead extending said active part, this bead having a section greater than that of said first region of the neck.
- the height of said active part of the movable closure member can be at least equal to the height of said first zone.
- the cross section of the central cylindrical constriction is substantially identical to that of said second region of the neck.
- the section of the intermediate closure plug is less than that of said first region of the neck, and at least equal to that of said second region of this neck.
- the section of the intermediate closure plug can be greater than that of said second region of the neck.
- the height of the intermediate closure plug is greater than the height of the central constriction.
- the movable closure member comprises a rigid structure provided with a connection end piece and a flexible cap provided with an annular skirt comprising at least one lateral opening.
- the diameter of the second compartment is greater than the diagonal of the intermediate closure plug.
- the container initially has only one opening at the end of its neck.
- the container initially has a second opening at its end opposite to said neck, this opening being arranged to receive a closure plug after filling of the second compartment.
- the movable closure member is associated with a rigid connection end piece comprising a central duct and means of communication are provided for ensuring the passage of the solution obtained after mixing the components of said first compartment. in said central duct.
- said means for placing in communication comprise a lateral passage formed in said flexible skirt of the movable closure member.
- the movable closure member may be integral with a capsule and this capsule may comprise a vent and a hydrophobic filter to ensure the evacuation of the gases under pressure inside the first compartment.
- the movable intermediate plug is initially disposed in the central cylindrical constriction so that its height X inside the first compartment corresponds at most to the volume of liquid contained in this compartment and moved when the member mobile shutter is brought into the storage position in said second neck area.
- This movable intermediate plug can also be initially placed in the central cylindrical constriction so that its height X inside the first compartment corresponds to a volume less than that of the liquid contained in this compartment and moved when the movable closure member is brought into the storage position in said second neck area.
- the volume of liquid corresponding to the height La representing the difference in level between the surface N of the liquid and the inner end of the neck, is greater than the volume of the part of the intermediate closure plug which is located in said first compartment.
- fig. 1 to 7 illustrate the different filling phases of a container according to the invention, open at its two ends and intended to receive a liquid in one of the two compartments and a powder in the other compartment,
- fig. 8 to 15 illustrate the different filling phases of a container according to the invention closed at one of its ends and intended to receive a lyophilisate in one of the two compartments and a solvent in the other compartment,
- fig. 16 and 17 are detailed views which show what are the dimensional relationships existing between certain parts of the container and the closure members,
- fig. 18 and 19 illustrate the activation phases of the container according to the invention
- fig. 20 and 21 / illustrate forms of particular use of the container according to the invention
- fig. 22 and 23 show particularly advantageous embodiments of the container according to the invention.
- the container 10 comprises a first compartment 11 and a second compartment 12 which are separated by a central cylindrical throttle 13.
- the compartment 11 is extended by a neck 14. which comprises a first zone 15 close to the upper open end of the container and a second zone 16 between the first zone 15 and the interior of the container.
- Zone 15 has a section which is greater than that of zone 16.
- the two zones 15 and 16 are substantially cylindrical.
- the section of the second zone 16 is substantially equal to that of the central cylindrical throttle 13.
- an intermediate closure plug 17 is prepositioned in said first zone 15 of the neck 1.
- the section of this intermediate closure plug 17 is less than that of said first zone 15 but equal, or even slightly greater, than that of the second zone 16.
- This prepositioning which is made possible by the existence of said first zone at enlarged section, is extremely important for various reasons which will become evident in the remainder of this description.
- a first advantage which results from this is that it makes the installation of the intermediate closure plug 17 particularly easy.
- Fig. 2 illustrates the phase which consists in positioning the intermediate closure plug 17 in the central cylindrical throttle 13. This is done by means of a pusher 18 linked to a mechanism 19 (shown diagrammatically) by means of a rod 20. This pusher pushes the intermediate closure plug through the neck 14 to bring it into the position shown in the figure. Note that the height of the intermediate plug is greater than that of the central cylindrical throttle for reasons which will be explained later.
- the next phase which consists of filling the compartment 11 with a liquid 21, generally a solvent, is shown in FIG. 3.
- the liquid is supplied by means of a cannula 22 which penetrates into the neck 14 of the container 10.
- the seal between the two compartments is ensured by the intermediate closure plug 17 which is compressed in the central cylindrical constriction, in a manner sufficient to guarantee a tight closure of the compartment 12.
- Fig. 4 illustrates the start of the phase of setting up a movable closure member 23 in the first zone 15 of the neck 14.
- this member is prepositioned in said first zone 15 which has, as mentioned previously, a section greater than that of zone 16 of this pass.
- the movable closure member 23 has a cross section which is smaller than that of the zone 15 so that this prepositioning allows the gas 24 which overcomes the liquid 21 to escape and thus avoids inducing an overpressure inside of compartment 11. This is particularly important because, during this phase of prepositioning of the movable obturation member 23, the intermediate obturation plug 17, which is not subjected to any stress, does not move axially in the central cylindrical throttle 13.
- Fig. 5 illustrates an additional step in the production of the container, which consists in putting in place the sealed closure member 23 as well as a connection end piece 25 whose capsule-shaped rim 26 is engaged over the neck 14 and in particular on the bead 27 which equips the end of this neck.
- a protective cap 28 covers the connection end piece 25 and covers this end of the container.
- the movable closure member 23 has been pushed back at least into the second zone 16 of the neck. Since the section of this movable closure member, at least in its lower part, is greater than the section of said second zone 16, said closure member is compressed and ensures a sealed closure of the compartment 11. The movement of this member generates an overpressure inside the compartment 11, which has the effect of axially displacing the intermediate closure plug 17. Since the height of this closure plug intermediate is greater than that of the central cylindrical throttle, ' this displacement does not in any way modify the sealing conditions between the two compartments 11 and 12.
- the movable closure member 23 has at its upper part one or more beads 29 which both provide a retaining function and an aseptic barrier and which, when the device is used, serve as leaktight seals which prevent accidental passage of the solvent 21.
- the compartment 11 of which is filled and sealed the compartment 12 is prefilled by means of a powder 30 which is supplied by means of an appropriate device 31 and which is intended to be mixed with the solvent. before using the mixture thus obtained.
- a powder 30 which is supplied by means of an appropriate device 31 and which is intended to be mixed with the solvent. before using the mixture thus obtained.
- This phase is illustrated in fig. 6.
- the device 31 is engaged in the lower opening 32 of the container 10. Since the compartment 11 is filled and closed in leaktight manner at its two ends, no contamination by powder 30 can take place.
- fig. 7 represents the container ready for use or ready to be stored.
- a closure cap 33 has been put in place to close off the end 32 of the compartment 12.
- a capsule 34 has been crimped over said end 32 to ensure a definitive closure of this end of the container.
- Two tamper-evident labels 35 and 36 respectively have been put in place to prevent unauthorized opening of the container.
- Fig. 8 represents the first phase of filling a container 10 ′ which differs from the container 10 in that it is closed to one of its extremities. As before, it has a first compartment 11 'and a second compartment 12' separated by a central cylindrical throttle 13 '.
- the upper compartment 11 ' is extended by a neck 14' which comprises, as previously, a first zone 15 'and a second zone 16' having the same characteristics as the corresponding zones 15 and 16 of the preceding figures.
- the first zone consists in filling the lower compartment 12 'with a solution 40 which is poured out through a tube 41 which penetrates inside the container.
- the next phase consists in prepositioning an intermediate closure plug 17 'in the first zone 15' of the neck 14 '•
- This intermediate closure plug 17' has a lower zone 42 provided with notches or clearances 43 whose role will be explained below, and an upper zone 44 which is substantially identical to the intermediate closure plug 17.
- Fig. 10 illustrates the freeze-drying phase during which gases 45 can escape from the container 10 ′ despite the fact that the intermediate closure plug 17 ′ is prepositioned in the neck 14 ′ • This can be done thanks to the fact that the section of the lower part 42 of this intermediate closure plug is less than the section of said first zone 15 'of the neck 14' and thanks to the existence of the clearances 43.
- the intermediate closure plug 17 ′ is pressed into the neck 14 ′ by means of a plate 46 (shown diagrammatically) in the enclosure of the freeze-dryer and under inert gas. This phase is illustrated in fig. 11.
- Fig. 12 illustrates the final positioning of the intermediate plug 17 'in the central cylindrical throttle 13' by means of a pusher 18 identical to that which has been illustrated in FIG. 2.
- the intermediate closure plug 17 ' is pressed into the central cylindrical constriction 13' in a manner sufficient for its upper part 44 to be engaged in this constriction, the lower part 42 being located beyond this constriction inside the lower chamber 12 ′ containing the lyophilisate 47.
- Fig. 13 illustrates the phase of filling the compartment 11 ′ by means of a liquid 21 which is mainly a solvent, intended to be mixed with the lyophilisate 47. This filling is done through a cannula 22 identical to that represented in FIG. 3.
- the container 10 is then closed by means of a movable closure member 23 which is identical to that which is shown in FIG. 4.
- This shutter member is first of all prepositioned in the first zone 15 ′ of widened section of the neck 14 ′, as shown in FIG. 14, then pressed as previously during a phase which is represented by FIG. 15.
- This phase is identical in all respects to that which has been described with reference to FIG. 5.
- the establishment of the movable closure member 23 causes an overpressure inside the chamber 11 '.
- This overpressure is reflected on the intermediate closure plug 17 'which engages further forward in the central cylindrical throttle 13'. As before, its length is determined in such a way that this recess maintains the seal between the two compartments 11 'and 12'.
- the movable closure member 23 has, in its lower part, a diameter B which is less than the diameter A of the first area 15 of the neck 14.
- Li be the height of the second narrowed area 16 of the neck 14 and L2 the distance which separates the level N of the liquid in the upper compartment 11 from the base of the narrowed area 16.
- X be the height of the part of the intermediate closure plug 17 which exceeds in height the central cylindrical constriction 13 when the movable closure member 23 is prepositioned in the first zone 15 without being pushed into the second zone 16.
- L3 be the total height of the neck 14 and let Lo be the total height of the central cylindrical throttle 13.
- the volume of the liquid introduced into compartment 11 is calculated in such a way that before the closure of this compartment, the intermediate closure plug protrudes in height the central cylindrical throttle of the value X.
- the movable closure member 23 must be positioned in such a way that La is greater than or equal to X.
- the volume of gas which surmounts the level N of the liquid can be minimal and could theoretically be zero since it plays no role in the hydraulic operation of the system during the activation of the container. In other words, La could increase to reach the value Lx. In practice, a certain quantity of gas is allowed to remain which allows the tolerances of the glass to be absorbed and the compartment 11 to be filled without causing the solvent to overflow.
- the volume of liquid corresponding to the height La is greater than that corresponding to the value X.
- Fig. 18 illustrates the closing phase of the container, that is to say the positioning of the movable closure member 23 in the neck 14.
- the movable closure member 23 moves of a value and generates an equivalent displacement of the intermediate closure plug 17, assuming that the sections of these two components are identical. If the sections are different, the volume displaced by the movable closure member 23 is equivalent to that displaced by the intermediate closure plug 17.
- W can be equal to X. If one neglects the losses due to the friction of the intermediate closure plug against the walls of the central throttle, this plug moves with a stroke equivalent to W or with a stroke corresponding to a displaced volume W.
- Level N is brought to level N '.
- the stroke Z must be greater than Y.
- the level N 'defined above must be located in the zone corresponding to the stroke Z of the movable closure member, which guarantees the hydraulic operation of the system, that is to say the setting in communication between the two compartments.
- the container 10 is closed, at the level of the neck, by a movable closure member secured to a connection end piece 25 to which an injection syringe 50 is coupled.
- the movable closure member 23 is constituted by a flexible skirt 51 mounted on a cylindrical extension 52 of the connecting piece 25.
- the flexible skirt 51 has a lateral opening 53 which allows the injectable drug solution, which has after the two components initially contained in the two compartments 11 ′ and 12 ′ have been mixed, to flow through the central duct of the tubular extension of the connection end piece, then through the central duct of this end piece, up to in the syringe 50.
- the two central conduits mentioned above are advantageously separated by a filter 54 which retains any solid particles present in the mixture.
- the movable closure member 23 does not have a lateral opening.
- this movable closure member is mounted on a support integral with the connection endpiece 25, which has lateral openings 55.
- a hydrophobic filter 56 can also be interposed on the discharge path of the mixture, and a vent 57 for evacuating gases is provided in the capsule carrying the connection end piece 25.
- Some substances have the particularity of generating quantities carbon dioxide when mixing the two components. This is the case, for example, with fourth generation cephalosporins, of which 1 g of powder mixed with 4 to 5 ml of water can produce up to 50 ml of COa.
- FIGS. 22 and 23 comprises a movable closure member 70 constituted by an elastomer plug whose flexibility is given by the existence of a central cavity 71.
- this plug can be prepositioned in the first zone 15 of enlarged section of the neck 14, before being placed in a sealed manner in the second zone 16 of narrowed section and crimped by means of a safety cap 72.
- the container shown has many advantages over the prior art.
- the embodiment which is open at both ends makes it possible to carry out a final sterilization after filling by autoclaving of the solvent at 120 ° C. This removes bactericidal preservatives from the solvent.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Package Specialized In Special Use (AREA)
- Closures For Containers (AREA)
- External Artificial Organs (AREA)
- Cartons (AREA)
- Stackable Containers (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH3358/89 | 1989-09-14 | ||
CH335889 | 1989-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0448656A1 true EP0448656A1 (en) | 1991-10-02 |
EP0448656B1 EP0448656B1 (en) | 1993-12-01 |
Family
ID=4254252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19900912873 Expired - Lifetime EP0448656B1 (en) | 1989-09-14 | 1990-09-13 | Elongate container having two compartments, one being an extension of the other |
Country Status (8)
Country | Link |
---|---|
US (1) | US5291991A (en) |
EP (1) | EP0448656B1 (en) |
JP (1) | JPH0683719B2 (en) |
AT (1) | ATE97800T1 (en) |
DE (1) | DE69004949T2 (en) |
DK (1) | DK0448656T3 (en) |
ES (1) | ES2047947T3 (en) |
WO (1) | WO1991004003A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687567B1 (en) * | 1992-02-20 | 1994-05-27 | Merck Sharp & Dohme | PACKAGING AND DISPENSING ASSEMBLY FOR SEPARATELY CONDITIONING TWO LIQUID COMPONENTS, AND MAKING THEIR EXTEMPORANEOUS MIXTURE ON THE FIRST USE, AND METHOD FOR MANUFACTURING SUCH AN ASSEMBLY. |
US5405001A (en) * | 1994-04-29 | 1995-04-11 | Clinetics Corporation | Removable and pierceable activation closure for two-compartment vial |
CA2185494A1 (en) | 1995-09-27 | 1997-03-28 | Jean-Pierre Grimard | Resealable vial with connector assembly having a membrane and pusher |
US5702019A (en) * | 1995-09-27 | 1997-12-30 | Becton Dickinson France S.A. | Vial having resealable membrane assembly activated by a medical delivery device |
US6003702A (en) * | 1995-09-27 | 1999-12-21 | Becton Dickinson France, S.A. | Vial with resealable connector assembly having a membrane and a multi-configuration fluid access device |
US5871110A (en) * | 1996-09-13 | 1999-02-16 | Grimard; Jean-Pierre | Transfer assembly for a medicament container having a splashless valve |
US5873872A (en) * | 1996-09-17 | 1999-02-23 | Becton Dickinson And Company | Multipositional resealable vial connector assembly for efficient transfer of liquid |
US5925029A (en) * | 1997-09-25 | 1999-07-20 | Becton, Dickinson And Company | Method and apparatus for fixing a connector assembly onto a vial with a crimp cap |
US6213994B1 (en) | 1997-09-25 | 2001-04-10 | Becton Dickinson France, S.A. | Method and apparatus for fixing a connector assembly onto a vial |
US6090093A (en) * | 1997-09-25 | 2000-07-18 | Becton Dickinson And Company | Connector assembly for a vial having a flexible collar |
US6382442B1 (en) | 1998-04-20 | 2002-05-07 | Becton Dickinson And Company | Plastic closure for vials and other medical containers |
US6003566A (en) | 1998-02-26 | 1999-12-21 | Becton Dickinson And Company | Vial transferset and method |
US6681946B1 (en) | 1998-02-26 | 2004-01-27 | Becton, Dickinson And Company | Resealable medical transfer set |
US6209738B1 (en) | 1998-04-20 | 2001-04-03 | Becton, Dickinson And Company | Transfer set for vials and medical containers |
US6957745B2 (en) * | 1998-04-20 | 2005-10-25 | Becton, Dickinson And Company | Transfer set |
US6378714B1 (en) | 1998-04-20 | 2002-04-30 | Becton Dickinson And Company | Transferset for vials and other medical containers |
US6904662B2 (en) * | 1998-04-20 | 2005-06-14 | Becton, Dickinson And Company | Method of sealing a cartridge or other medical container with a plastic closure |
US6575208B2 (en) * | 2000-04-04 | 2003-06-10 | M.L.I.S. Projects Ltd. | Method and apparatus for filling a multi-compartment container |
JP2003235938A (en) * | 2002-02-21 | 2003-08-26 | Taisei Kako Co Ltd | Infusion vessel |
US7482116B2 (en) | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
US8464910B2 (en) * | 2008-03-14 | 2013-06-18 | Solutions Biomed, Llc | Multi-chamber container system for storing and mixing fluids |
US8252228B1 (en) * | 2008-10-13 | 2012-08-28 | Abbott Cardiovascular Systems Inc. | Methods for sterilizing carriers for treatment of a kidney |
WO2010056881A1 (en) * | 2008-11-12 | 2010-05-20 | Solutions Biomed, Llc | Multi-chamber container system for storing and mixing liquids |
WO2010056871A2 (en) | 2008-11-12 | 2010-05-20 | Solutions Biomed, Llc | Two-part disinfectant system and related methods |
EP3150702B1 (en) | 2011-06-19 | 2021-05-19 | DNA Genotek, Inc. | Devices, solutions and methods for sample collection |
US11712692B2 (en) | 2018-11-20 | 2023-08-01 | Spectrum Solutions L.L.C. | Sample collection system including sealing cap and valve |
US11701094B2 (en) | 2019-06-20 | 2023-07-18 | Spectrum Solutions L.L.C. | Sample collection system including valve and plug assemblies |
CN112007575B (en) * | 2020-08-26 | 2022-04-12 | 山西医科大学 | Liquid passing device |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2549417A (en) * | 1949-08-10 | 1951-04-17 | Frederick M Turnbull | Syringe ampoule |
BE503143A (en) * | 1950-05-09 | |||
US2869745A (en) * | 1954-02-05 | 1959-01-20 | Compule Corp | Plunger closures of containers |
US2813649A (en) * | 1955-06-30 | 1957-11-19 | Lipari Michael | Receptacles |
US2807384A (en) * | 1956-03-12 | 1957-09-24 | Lipari Michael | Compartmental dispensing receptacle |
US3206080A (en) * | 1962-07-23 | 1965-09-14 | Abbott Lab | Dispensing assembly |
US3198194A (en) * | 1963-05-13 | 1965-08-03 | Upjohn Co | Admixing storage container with means preventing inadvertent removal of closure means |
US3464414A (en) * | 1963-07-31 | 1969-09-02 | Upjohn Co | Mixing vial construction |
US3946732A (en) * | 1973-08-08 | 1976-03-30 | Ampoules, Inc. | Two-chamber mixing syringe |
US4102451A (en) * | 1977-05-25 | 1978-07-25 | Eli Lilly And Company | Mixing vial |
US4267925A (en) * | 1979-10-01 | 1981-05-19 | The Upjohn Company | Closure for large-volume vial |
US4258845A (en) * | 1979-11-20 | 1981-03-31 | The Upjohn Company | Activator closure for two-compartment vial |
US4331233A (en) * | 1980-05-30 | 1982-05-25 | The Upjohn Company | Activation closure for vial |
JPS6346160A (en) * | 1986-08-14 | 1988-02-27 | 帝三製薬株式会社 | Container for injection drug |
CA2006582A1 (en) * | 1988-12-27 | 1990-06-27 | Gabriel Meyer | Storage and transfer bottle for storing two components of a medicinal substance |
-
1990
- 1990-09-13 AT AT90912873T patent/ATE97800T1/en not_active IP Right Cessation
- 1990-09-13 EP EP19900912873 patent/EP0448656B1/en not_active Expired - Lifetime
- 1990-09-13 DK DK90912873T patent/DK0448656T3/en active
- 1990-09-13 DE DE69004949T patent/DE69004949T2/en not_active Expired - Fee Related
- 1990-09-13 US US07/675,904 patent/US5291991A/en not_active Expired - Lifetime
- 1990-09-13 ES ES90912873T patent/ES2047947T3/en not_active Expired - Lifetime
- 1990-09-13 WO PCT/CH1990/000219 patent/WO1991004003A1/en active IP Right Grant
- 1990-09-13 JP JP51197090A patent/JPH0683719B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of WO9104003A1 * |
Also Published As
Publication number | Publication date |
---|---|
JPH0683719B2 (en) | 1994-10-26 |
US5291991A (en) | 1994-03-08 |
DE69004949D1 (en) | 1994-01-13 |
DK0448656T3 (en) | 1994-04-18 |
DE69004949T2 (en) | 1994-07-07 |
ATE97800T1 (en) | 1993-12-15 |
JPH04501819A (en) | 1992-04-02 |
EP0448656B1 (en) | 1993-12-01 |
ES2047947T3 (en) | 1994-03-01 |
WO1991004003A1 (en) | 1991-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0448656B1 (en) | Elongate container having two compartments, one being an extension of the other | |
EP0403626B1 (en) | Storage and transfer bottle designed for storing two components of a medicamental substance | |
EP0453555B1 (en) | Storage bottle containing a constituent of a medicinal solution | |
EP0462255B1 (en) | Two-compartment storage and transfer flask | |
EP0295265B1 (en) | Device for conditioning liquid or liquid and solid substances | |
EP1226077B1 (en) | Ready-to-use connecting device | |
CA2147414C (en) | Process for filling a sealed recipient in aseptic conditions | |
EP1919537B1 (en) | Syringe designed to be pre-filled then sterilized by steam autoclaving | |
EP1239808A1 (en) | Device for connection between a vessel and a container and ready-to-use assembly comprising same | |
CA2156492A1 (en) | Prefilled storing and transfer syringe for a substance | |
FR2511653A1 (en) | DRILLABLE CLOSURE ELEMENT FOR VIAL | |
EP0466544B1 (en) | Dosing pump for pressure spraying with intrinsic safety | |
WO1990007318A1 (en) | Storage and transfer bottle designed for storing a component of a medicamental substance | |
WO1999036029A1 (en) | Sealed confinement device for connecting a container and means for delivering a substance | |
CA2299595C (en) | Packaging for mixing a product with several components | |
EP1034772A1 (en) | Device for transfering a substance contained in a vial to a pouch containing a solute | |
WO1987001042A1 (en) | Prefilled syringe | |
FR2767514A1 (en) | MIXER BOTTLE COMBINING TWO INSULATED COMPONENTS BEFORE THEY ARE COLLECTED AND INJECTED WITH A SYRINGE | |
EP0879191B1 (en) | Device for dispensing a fluid material from a sealed container | |
CA2045501A1 (en) | Elongate container having two separate compartments, one being an exten sion of the other | |
FR2746653A3 (en) | SYRINGE FOR MEDICAL USE | |
FR3066478A1 (en) | ASSEMBLY FOR PACKAGING A FLUIDIC PRODUCT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19910415 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19921120 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
REF | Corresponds to: |
Ref document number: 97800 Country of ref document: AT Date of ref document: 19931215 Kind code of ref document: T |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: BECTON DICKINSON FRANCE S.A. |
|
REF | Corresponds to: |
Ref document number: 69004949 Country of ref document: DE Date of ref document: 19940113 |
|
ITF | It: translation for a ep patent filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2047947 Country of ref document: ES Kind code of ref document: T3 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19940203 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
EAL | Se: european patent in force in sweden |
Ref document number: 90912873.8 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20020819 Year of fee payment: 13 Ref country code: FR Payment date: 20020819 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20020820 Year of fee payment: 13 Ref country code: AT Payment date: 20020820 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20020821 Year of fee payment: 13 Ref country code: CH Payment date: 20020821 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20020828 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20020904 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20020913 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20020930 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20021009 Year of fee payment: 13 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030913 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030913 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030913 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030914 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030915 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030930 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030930 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030930 |
|
BERE | Be: lapsed |
Owner name: S.A. *BECTON DICKINSON FRANCE Effective date: 20030930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040401 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040401 |
|
EUG | Se: european patent has lapsed | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20030913 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040528 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20040401 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20030915 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050913 |